NEW PEDIATRIC RESEARCH STUDY: Fall 2018
Meningitis Vaccine Research Opportunity
Meningococcal meningitis is a serious illness that can occur at any age. While vaccination is the best way to prevent infection from the different types of meningitis, children under the age of ten, even fully vaccinated, remain at risk for a form called invasive meningococcal disease (IMD). This is because currently there is no licensed IMD vaccination for children until they turn ten years of age.
Rochester Clinical Research and Legacy Pediatrics are participating in a research study to evaluate the effectiveness of a vaccine protective against IMD starting in infancy. We are currently seeking to enroll 2-month-old infants in this study which requires six total office visits. The first four will coincide with 2-, 4-, 6- and 12- month well-visits. The series of injections will be administered alongside routine immunizations during the appointments. There will be telephone call interviews between visits to discuss any noted reactions.
Speak with us today to see if your infant can enroll now or in the future.
Think your child may qualify?
- Is your child 2 months old?
- Please note, other conditions may apply
Compensation for time and travel:
Compensation for time and travel may be available for qualified participants up to $300.
How to contact us:
If you are interested in participating in the above study, please inquire with the Legacy Pediatrics office.
By March the winter season of repeated colds and the flu have caused some children to get several ear infections. At Legacy, most of our patients are on the NIH study and we find out which bacteria cause the ear infection and then give antibiotics that perfectly match the child’s system to kill the germ. For the other children not in the study, we use the knowledge gained from those in the study to make the best guess as to the most likely bacterial strain and the most likely best antibiotic. So we are doing the same as the other pediatricians in Rochester and across the country – but even better because at least we know what bacteria are in our practice population, and what antibiotics are working best for the study children.
Our ear immunity study has completed six years now and time for an update to share with you what we have found.
An emerging “superbug” that causes ear infections in children and is resistant to multiple antibiotics can only be treated with an adult medication, researchers report. Read the full story here.
Two Rochester, N.Y., pediatricians report finding a multiple antibiotic-resistant strain of Streptococcus pneumoniae that caused ear infections in nine children in their practice over three years. The only antibiotic that was effective in treating these infections was levofloxacin, which isn’t approved by the U.S. Food and Drug Administration for use in children.